Zomedica Corp. (ZOMDF) Q1 2026 Earnings Call Transcript

Operator

Welcome to Zomedica’s First Quarter 2026 Financial Results and focus on the companion animal vet tech market. Today, we’ll examine the largest and most consistent segment in veterinary medicine, companion animal care and the role it plays in driving recurring scalable growth. We’ll walk through the market opportunity and how Zomedica is positioned within daily clinical workflows.

Before we begin, I want to remind current and potential investors that we will be making various remarks about future expectations, plans and prospects that are considered forward-looking statements. There are risks that actual results may differ from these statements. We refer you to the safe harbor statement on screen or to the Risk Factors sections of our public filings, which can be found on our website under Investor filings, EDGAR and SEDAR+. The statements are made as of today, May 29, 2026, and reflect our expectations as of today. Thank you for joining us for Zomedica’s investor webinar series. We’re excited to have you with us as we take a closer look at our company, our innovative product platforms and the passionate people driving our success. This series is designed to give you a deeper understanding of how we’re delivering value to veterinarians and to our shareholders.

At Zomedica, our mission is to deliver innovative diagnostic and therapeutic technologies that empower veterinarians to focus on what they love most, enhancing pet care and improving pet parent satisfaction. Equally important, we help vets with what they need most, streamlining workflow, increasing cash flow and boosting practice profitability. At Zomedica, our mission is guided by what we call our 5